Allurion Technologies (NYSE:ALUR – Get Free Report) and Dynatronics (NASDAQ:DYNT – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, dividends, valuation, risk, profitability and institutional ownership.
Institutional and Insider Ownership
21.4% of Allurion Technologies shares are held by institutional investors. Comparatively, 4.2% of Dynatronics shares are held by institutional investors. 22.4% of Allurion Technologies shares are held by company insiders. Comparatively, 8.0% of Dynatronics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Risk and Volatility
Allurion Technologies has a beta of -0.62, meaning that its stock price is 162% less volatile than the S&P 500. Comparatively, Dynatronics has a beta of 0.13, meaning that its stock price is 87% less volatile than the S&P 500.
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Allurion Technologies | $53.47 million | 0.15 | -$80.61 million | ($12.00) | -0.26 |
| Dynatronics | $32.53 million | 0.03 | -$2.70 million | ($0.96) | -0.14 |
Dynatronics has lower revenue, but higher earnings than Allurion Technologies. Allurion Technologies is trading at a lower price-to-earnings ratio than Dynatronics, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Allurion Technologies and Dynatronics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Allurion Technologies | -71.24% | N/A | -56.75% |
| Dynatronics | -8.88% | -41.41% | -10.12% |
Analyst Recommendations
This is a summary of recent ratings and target prices for Allurion Technologies and Dynatronics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Allurion Technologies | 0 | 1 | 3 | 1 | 3.00 |
| Dynatronics | 0 | 0 | 0 | 0 | 0.00 |
Allurion Technologies currently has a consensus target price of $71.88, suggesting a potential upside of 2,218.55%. Given Allurion Technologies’ stronger consensus rating and higher possible upside, equities research analysts plainly believe Allurion Technologies is more favorable than Dynatronics.
Summary
Allurion Technologies beats Dynatronics on 9 of the 14 factors compared between the two stocks.
About Allurion Technologies
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
About Dynatronics
Dynatronics Corporation, a medical device company, designs, manufactures, and sells physical therapy, rehabilitation, orthopedics, pain management, and athletic training products in the United States. The company offers orthopedic soft bracing products include cervical collars, shoulder immobilizers, arm slings, wrist and elbow supports, abdominal and lumbosacral supports, maternity supports, knee immobilizers and supports, ankle walkers and supports, plantar fasciitis splints, and cold therapy products. It also offers physical therapy and rehabilitation products, which include therapeutic modality devices comprising electrotherapy, ultrasound, phototherapy, traction, hot and cold therapy, and electrodes; and power and manually operated treatment tables, mat platforms, work tables, parallel bars, training stairs, weight racks, and other related equipment. In addition, the company manufactures and distributes clinical supplies, including exercise bands and tubing, lotions and gels, orthopedic bracings, paper products, and other related supplies. It markets its products under the Dynatron, Dynatron Solaris, Dynaheat, BodyIce, Powermatic, Bird & Cronin, Physician's Choice, Hausmann, PROTEAM, and Mammoth brands. The company sells its products to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, hospitals, and retail distributors and equipment manufacturers. It also exports its products in Asia, Latin America, and the Middle East. Dynatronics Corporation was founded in 1979 and is headquartered in Eagan, Minnesota.
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
